Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score.
Amy KunchokJeannette Lechner-ScottFranco GranellaMaria TrojanoRaed AlroughaniPatrizia SolaDiana FerraroAlessandra LugaresiMarco OnofrjSerkan OzakbasGuillermo IzquierdoPierre GrammondJose Luis Sanchez-MenoyoBart Van WijmeerschCavit BozEugenio PucciPamela McCombeFrancois Grand'MaisonDaniele SpitaleriSteve VucicRaymond HuppertsVilija JokubaitisMaria Pia SormaniHelmut ButzkuevenTomas Kalinciknull nullPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2020)
We have validated the MAGNIMS score in RRMS and extended its application to three other DMTs: 1 relapse and ⩾3 T2 lesions or ⩾2 relapses predicted worsening of disability. Contrast-enhancing lesions did not substantially improve the prognostic score.